DE1359854U - - Google Patents

Info

Publication number
DE1359854U
DE1359854U DENDAT1359854D DE1359854DU DE1359854U DE 1359854 U DE1359854 U DE 1359854U DE NDAT1359854 D DENDAT1359854 D DE NDAT1359854D DE 1359854D U DE1359854D U DE 1359854DU DE 1359854 U DE1359854 U DE 1359854U
Authority
DE
Germany
Prior art keywords
jin
ftt
vstorn
tßn
tttplt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1359854D
Other languages
German (de)
English (en)
Publication of DE1359854U publication Critical patent/DE1359854U/de
Active legal-status Critical Current

Links

Landscapes

  • Dental Preparations (AREA)
  • Cosmetics (AREA)
  • Prostheses (AREA)
DENDAT1359854D Active DE1359854U (enExample)

Publications (1)

Publication Number Publication Date
DE1359854U true DE1359854U (enExample)

Family

ID=673895

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1359854D Active DE1359854U (enExample)

Country Status (1)

Country Link
DE (1) DE1359854U (enExample)

Similar Documents

Publication Publication Date Title
DE1359854U (enExample)
CA2350246C (en) Controlled delivery of active agents
US5897878A (en) Method for administering steroid
US4915953A (en) Dosage form for delivering acetaminophen or phenylpropanolamine
US5830502A (en) Injection-molded dosage form
AU619454B2 (en) Dispenser comprising displaceable matrix with solid state properties
EP1539144B1 (en) Multistage formulation containing a biguanide and a thiazolidinedione derivative
US5326571A (en) Dosage forms comprising polymers comprising different molecular weights
US4940465A (en) Dispenser comprising displaceable matrix with solid state properties
IE892845A1 (en) Controlled-release oral dosage forms comprising different cellulose ethers
US20100316708A1 (en) Novel Pharmaceutical Formulation Containing A Biguanide and a Thiazolidinedione Derivative
US4732915A (en) Process for increasing solubility of drug
US5266332A (en) Method for administering anti-Parkinson drug
WO2006044077A2 (en) Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
US20050287214A1 (en) Squeeze controlled oral dosage form
IL297368A (en) Long-acting peptide tyrosine kinase (pyy) analogs and methods of use
EP2848245A1 (en) Bosentan controlled release oral preparation
KR101010325B1 (ko) 텔미사르탄 및 히드로클로로티아지드를 함유하는 약제학적 조성물
DE1460624U (enExample)
DE1401201U (enExample)
CA1336070C (en) Controlled release dosage form comprising different cellulose ethers
DE1438762U (enExample)
DE1455910U (enExample)
AU731358B2 (en) Injection-molded dosage form
DE1288387U (enExample)